This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Delivered as a Hybrid Event from September 20-30, 2021
Live In-Person Experience Delivered September 20-23Boston Convention and Exhibition Center

Eleni Papanikolaou
Manager Hemapoietic Stem Cell Gene Therapy and Graft Engineering at Miltenyi Biotec, Germany


Eleni Papanikolaou is Manager of Hemopoietic Stem Cell Gene Therapy and Graft Engineering at the Department of Research and Development of Miltenyi Biotec, in Bergisch-Gladbach, Germany and a Lecturer of Gene Transfer and Gene Therapy of the Department of Basic Medical Sciences of the School of Medicine, at the National & Kapodistrian University of Athens (NKUA), in Athens, Greece.

She graduated from the Department of Biology, Faculty of Sciences at the Aristotle University of Thessaloniki (AUTH) in 1995. She continued with her doctoral thesis in Molecular Virology at the Laboratory of Microbiology of the Department of Biology, AUTH, on the study and characterization of the products of the open reading frame U86 / 87 of human herpesvirus type 6 (Human Herpesvirus 6, HHV-6). After completing her doctorate, she continued her postdoctoral work at the Department of Medical Genetics of the University of Washington, in Seattle WA, USA (2003-2005), enrolled in the prestigious Program of Excellence in Gene Therapy (PEGT) under the supervision of Professor George Stamatoyannopoulos. From 2005 to 2013 Dr Papanikolaou led a research group at the Gene Therapy Lab of the Biomedical Research Foundation of the Academy of Athens ( before becoming a Lecturer of Gene Therapy at the University of Athens. In May 2018 she joined the RnD Department of Miltenyi Biotec as a Manager of hemopoietic stem cell gene therapy and graft engineering.

Her research focuses on translating cutting-edge research into state-of-the-art products and services in the field of hemopoiesis and to develop best practices for novel gene and cell therapeutic approaches for hematological diseases based on classical gene addition or via genome editing. Among various translational research studies, a special emphasis is given to thalassemia, a disease of special interest for Greece, not only because of significant patient morbidity but for the enormous financial burden on the health system, as well. Dr Papanikolaou’s work is reflected in >20 publications that have received >1300 citations and h-index= 9 (Google scholar, 17/09/2019). She has given several invited lectures at national and international conferences, universities and biotech companies and has trained several junior scientists. She has served as ad hoc reviewer for various scientific journals (e.g. Molecular Therapy, Gene and Cell Therapy Insights, Metabolism, Continuing Cardiology Education etc.) and as an expert evaluator for the European Commission (William Harvey International Translational Research Academy), and National Research Grant Funding Agencies of Greece and Cyprus. She has received more than 15 national and international awards and has served as co-PI of at least two European Commission-funded collaborative research programmes involving gene therapy laboratories of excellence across Europe.

Professor Papanikolaou teaches Biology and Genetics to undergraduate medical students and she also teaches various aspects of Gene Therapy in three doctoral programmes of NKUA.

ORCID ID: 0000-0002-9008-5823

Agenda Sessions

  • Engineering of hemopoietic stem cells on the CliniMACS Prodigy®